The Latest Breaking News from Moderna

The health board confirmed the plans as the booster programmes continues across Lanarkshire.

Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Saudi Arabia’s Ministry of Hajj and Umrah has decided that travelers inbound to the Kingdom who have received a full dose of one of the approved vaccines, including Oxford-AstraZeneca, Pfizer-BioNTech, Johnson & Johnson, Moderna, are exempt from the need to quarantine. In a statement to Asharq Al-Awsat, the Ministry revealed…

Public Storage (NYSE: PSA) helps organize and store your belongings, and over the past year delivered astonishing returns.

Moderna is aiming to launch a single vaccine that will offer protection against flu and Covid. During the booster roll out, those who were offered a flu jab were also offered a booster on the same day.

For many Australians, it’s now time for a COVID booster – but which one should you be getting? Read our handy guide to find out.

Analysts have provided the following ratings for Moderna (NASDAQ:MRNA) within the last quarter:

France registers 464,769 new Covid-19 infections over the last 24 hours; Italy’s cases jump from 83,403 a day earlier

Combined vaccine should be ready in time for winter infectious season in 2023, says drug firm’s chief executive